BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37550517)

  • 1. Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasms.
    Grockowiak E; Korn C; Rak J; Lysenko V; Hallou A; Panvini FM; Williams M; Fielding C; Fang Z; Khatib-Massalha E; García-García A; Li J; Khorshed RA; González-Antón S; Baxter EJ; Kusumbe A; Wilkins BS; Green A; Simons BD; Harrison CN; Green AR; Lo Celso C; Theocharides APA; Méndez-Ferrer S
    Nat Cancer; 2023 Aug; 4(8):1193-1209. PubMed ID: 37550517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hematopoietic Microenvironment in Myeloproliferative Neoplasms: The Interplay Between Nature (Stem Cells) and Nurture (the Niche).
    Zhan H; Kaushansky K
    Adv Exp Med Biol; 2020; 1273():135-145. PubMed ID: 33119879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloproliferative neoplasm stem cells.
    Mead AJ; Mullally A
    Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms.
    Arranz L; Sánchez-Aguilera A; Martín-Pérez D; Isern J; Langa X; Tzankov A; Lundberg P; Muntión S; Tzeng YS; Lai DM; Schwaller J; Skoda RC; Méndez-Ferrer S
    Nature; 2014 Aug; 512(7512):78-81. PubMed ID: 25043017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
    Miller LH; Qu CK; Pauly M
    Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.
    Schepers K; Pietras EM; Reynaud D; Flach J; Binnewies M; Garg T; Wagers AJ; Hsiao EC; Passegué E
    Cell Stem Cell; 2013 Sep; 13(3):285-99. PubMed ID: 23850243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The marrow stem cell niche in normal and malignant hematopoiesis.
    Kaushansky K; Zhan H
    Ann N Y Acad Sci; 2020 Apr; 1466(1):17-23. PubMed ID: 30767234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging.
    Ho YH; Del Toro R; Rivera-Torres J; Rak J; Korn C; García-García A; Macías D; González-Gómez C; Del Monte A; Wittner M; Waller AK; Foster HR; López-Otín C; Johnson RS; Nerlov C; Ghevaert C; Vainchenker W; Louache F; Andrés V; Méndez-Ferrer S
    Cell Stem Cell; 2019 Sep; 25(3):407-418.e6. PubMed ID: 31303548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.
    Kaushansky K; Zhan H
    Adv Biol Regul; 2018 Aug; 69():11-15. PubMed ID: 29970351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modelling of the hematopoietic stem cell-niche system: Clonal dominance based on stem cell fitness.
    Pedersen RK; Andersen M; Stiehl T; Ottesen JT
    J Theor Biol; 2021 Jun; 518():110620. PubMed ID: 33587928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targets in MPNs and potential therapeutics.
    Levy G; Mambet C; Pecquet C; Bailly S; Havelange V; Diaconu CC; Constantinescu SN
    Int Rev Cell Mol Biol; 2022; 366():41-81. PubMed ID: 35153006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals.
    Zacharaki D; Ghazanfari R; Li H; Lim HC; Scheding S
    Eur J Haematol; 2018 Jul; 101(1):57-67. PubMed ID: 29645296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice.
    Shide K; Kameda T; Kamiunten A; Ozono Y; Tahira Y; Yokomizo-Nakano T; Kubota S; Ono M; Ikeda K; Sekine M; Akizuki K; Nakamura K; Hidaka T; Kubuki Y; Iwakiri H; Hasuike S; Nagata K; Sashida G; Shimoda K
    Blood; 2020 Jul; 136(1):106-118. PubMed ID: 32219445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging of the Hematopoietic Stem Cell Niche: New Tools to Answer an Old Question.
    Matteini F; Mulaw MA; Florian MC
    Front Immunol; 2021; 12():738204. PubMed ID: 34858399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal regulation of bone marrow stem cell niches.
    Fielding C; Méndez-Ferrer S
    F1000Res; 2020; 9():. PubMed ID: 32595942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
    Yung Y; Lee E; Chu HT; Yip PK; Gill H
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.
    Caselli A; Olson TS; Otsuru S; Chen X; Hofmann TJ; Nah HD; Grisendi G; Paolucci P; Dominici M; Horwitz EM
    Stem Cells; 2013 Oct; 31(10):2193-204. PubMed ID: 23818291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Niches of Hematopoietic Stem and Progenitor Cells.
    Kandarakov O; Belyavsky A; Semenova E
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasms.
    Ikeda K; Ogawa K; Takeishi Y
    Fukushima J Med Sci; 2012; 58(2):91-100. PubMed ID: 23237864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.